Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Auditor change
Consulting agrmnt
|
|
PIERIS PHARMACEUTICALS, INC. (PIRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 10/24/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/27/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 04/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Nussbaum Ran reports a 6.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/07/2020 |
SC 13G
| BlackRock Inc. reports a 6.2% stake in PIERIS PHARMACEUTICALS INC |
| 11/14/2019 |
SC 13G
| EcoR1 Capital, LLC reports a 8.8% stake in Pieris Pharmaceuticals, Inc. |
| 10/07/2019 |
SC 13G
| Aquilo Capital Management, LLC reports a 5.9% stake in PIERIS PHARMACEUTICALS, INC. |
| 06/17/2016 |
SC 13G
| PIERIS PHARMACEUTICALS, INC. reports a 10% stake in Pieris Pharmaceuticals, Inc. |
| 02/16/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/12/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|